Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated to version v2.11.0, with new results submitted, while the previous version v2.10.5 has been removed along with a notice about delays in study record information.SummaryDifference4%
- Check14 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.3%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
- Check78 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.